 |
|
Serum prohepcidin levels in chronic hepatitis C, alcoholic liver disease, and nonalcoholic fatty liver disease
Sang Hyub Lee, Sook-Hyang Jeong, Young Soo Park, Jin-Hyeok Hwang, Jin-Wook Kim, Nayoung Kim, Dong Ho Lee
Korean J Hepatol. 2010;16(3):288-294. Published online 2010 Sep 30 DOI: https://doi.org/10.3350/kjhep.2010.16.3.288
|
|
Citations to this article as recorded by
 Hemoglobin and Its Z Score Reference Intervals in Febrile Children: A Cohort Study of 98,572 Febrile Children
Chu-Yin Cheng, Ting-Hsuan Hsu, Ya-Ling Yang, Ying-Hsien Huang
Children.2023; 10(8): 1402. CrossRef A Study of Changes in Prohepcidin and Iron Levels in Patients with Liver Transplant and Chronic Viral Hepatitis
Özlem ÖZDEMİR, Mesut AKARSU, Pınar TOSUN TAŞAR, Faize YÜKSEL, Aylin BACAKOĞLU, Tarkan ÜNEK, Fatih DEMİRKAN, Sedat KARADEMİR
Namık Kemal Tıp Dergisi.2023; 11(1): 66. CrossRef Liver Sinusoidal Endothelial Cells at the Crossroad of Iron Overload and Liver Fibrosis
Sara Petrillo, Marta Manco, Fiorella Altruda, Sharmila Fagoonee, Emanuela Tolosano
Antioxidants & Redox Signaling.2021; 35(6): 474. CrossRef Inflammatory and cardiovascular diseases biomarkers in chronic hepatitis C virus infection: A review
Ahmed Babiker, Mohamed Hassan, Safwan Muhammed, Gregory Taylor, Bhawna Poonia, Anoop Shah, Shashwatee Bagchi
Clinical Cardiology.2020; 43(3): 222. CrossRef C-Reactive Protein Concentration Can Help to Identify Bacteremia in Children Visiting the Emergency Department: A Single Medical Center Experience
I-Min Chiu, Ying-Hsien Huang, Chih-Min Su, Chia-Te Kung, Chao-Jui Li, Chih-Ho Chen, Kuo-Su Tang, Kuang-Che Kuo
Pediatric Emergency Care.2020; 36(6): 291. CrossRef Relationship of serum haemojuvelin and hepcidin levels with iron level and erythropoietin requirement in prevalent hepatitis C virus positive haemodialysis patients
Heba W. El Said, Khaled H. Abou Seif, Yasser S. Ahmed, Hesham A. Abou Elleil, Tamer W. El Said, Maha A. Behairy, Mohamed M. Mohamed, Fatma A. Ahmed
Nephrology.2018; 23(4): 323. CrossRef Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker
Ying-Hsien Huang, Ho-Chang Kuo
International Journal of Molecular Sciences.2017; 18(4): 820. CrossRef Hepcidin in morbidly obese women with non-alcoholic fatty liver disease
Teresa Auguet, Gemma Aragonès, Alba Berlanga, Salomé Martínez, Fàtima Sabench, Jessica Binetti, Carmen Aguilar, José Antonio Porras, Alicia Molina, Daniel Del Castillo, Cristóbal Richart, Pavel Strnad
PLOS ONE.2017; 12(10): e0187065. CrossRef Alcoholic liver disease: Clinical and translational research
Manuela G. Neuman, Stephen Malnick, Yaakov Maor, Radu M. Nanau, Ehud Melzer, Peter Ferenci, Helmut K. Seitz, Sebastian Mueller, Haim Mell, Didier Samuel, Lawrence B. Cohen, Kusum K. Kharbanda, Natalia A. Osna, Murali Ganesan, Kyle J. Thompson, Iain H. McK
Experimental and Molecular Pathology.2015; 99(3): 596. CrossRef The Wide and Complex Field of NAFLD Biomarker Research: Trends
Erika Wichro, Tanja Macheiner, Jasmin Schmid, Barbara Kavsek, Karine Sargsyan
ISRN Hepatology.2014; 2014: 1. CrossRef Serum hepcidin levels and iron metabolism in obese children with and without fatty liver: case–control study
Fatih Demircioğlu, Gökhan Görünmez, Emine Dağıstan, Sevil Bilir Göksügür, Mervan Bekdaş, Mehmet Tosun, Betül Kızıldağ, Erol Kısmet
European Journal of Pediatrics.2014; 173(7): 947. CrossRef Serum prohepcidin concentrations in rheumatoid arthritis and its relation to disease activity
Ahmad Emerah, Samah F. Abbas, Heba F. Pasha
Egyptian Rheumatology and Rehabilitation.2014; 41(3): 130. CrossRef Lower serum prohepcidin levels associated with lower iron and erythropoietin requirements in hemodialysis patients with chronic hepatitis C
Yasar Caliskan, Berna Yelken, Abdullah Ozkok, Numan Gorgulu, Halil Yazici, Aysegul Telci, Alaattin Yildiz
BMC Nephrology.2012;[Epub] CrossRef Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282YHFEmutations
James E. Nelson, Elizabeth M. Brunt, Kris V. Kowdley
Hepatology.2012; 56(5): 1730. CrossRef Serum prohepcidin levels are potential prognostic markers in patients with multiple myeloma
KOUICHI HARAGUCHI, HIROFUMI UTO, NOBUHITO OHNOU, MASAHITO TOKUNAGA, MAYUMI TOKUNAGA, ATAE UTSUNOMIYA, SHUICHI HANADA, HIROHITO TSUBOUCHI
Experimental and Therapeutic Medicine.2012; 4(4): 581. CrossRef
|